A Phase 3b Open-label Study Evaluating the Safety of Elexacaftor/Tezacaftor/Ivacaftor Combination Therapy in Cystic Fibrosis Subjects - VBX19-445-115

Project Details

StatusFinished
Effective start/end date26/09/1925/09/20

Funding

  • Vertex: AUD3,737.00
  • Vertex: AUD10,364.00